Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

SHE:300573 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	466.25	393.71	370.12	480.42	515.45	686.36
Cash & Short-Term Investments	466.25	393.71	370.12	480.42	515.45	686.36
Cash Growth	22.92%	6.37%	-22.96%	-6.80%	-24.90%	1744.12%
Accounts Receivable	316.21	325.92	277.93	252.1	194.96	170.62
Other Receivables	4.65	2.09	3.37	3.93	4.62	5.84
Receivables	320.85	328.02	281.3	256.03	199.58	176.46
Inventory	207.22	189.23	153.6	136.03	122.27	92.33
Other Current Assets	19.89	19.78	24.9	32.71	27.87	29.27
Total Current Assets	1,014	930.73	829.92	905.19	865.17	984.42
Property, Plant & Equipment	1,437	1,301	992.22	837.35	695.92	548.6
Long-Term Investments	15.91	11.67	10	-	-	-
Other Intangible Assets	212.97	222.62	134.57	78.29	27.66	22.83
Long-Term Deferred Tax Assets	20.63	19.68	22.5	38.57	23.77	30.45
Long-Term Deferred Charges	2.15	3.4	64.44	118.76	105.03	60.77
Other Long-Term Assets	40.09	50.01	74	45.68	65.39	39.78
Total Assets	2,743	2,539	2,128	2,024	1,783	1,687

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	28.24	35.49	17.73	17.57	19.46	13.31
Accrued Expenses	226.06	218.16	178.33	125.36	103.97	108.91
Short-Term Debt	50.03	70.05	200.17	70.06	-	100
Current Portion of Leases	6.4	7.6	6.28	6.87	7.12	4.18
Current Income Taxes Payable	41.17	56.3	22.84	5.74	-	11.69
Current Unearned Revenue	2.78	1.88	3.46	6.76	2.01	6.11
Other Current Liabilities	164.35	111.34	32.67	27.76	19.89	22.63
Total Current Liabilities	519.04	500.83	461.48	260.12	152.45	266.83
Long-Term Leases	2.73	4.38	8.86	2.22	6.69	7.1
Long-Term Unearned Revenue	58.48	55.72	64.13	71.58	71.5	68.42
Total Liabilities	580.25	560.93	534.48	333.92	230.63	342.35

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	357.32	246.43	175.25	124.59	88.56	88.1
Additional Paid-In Capital	720.06	829.93	866.51	891.01	852.36	782.68
Retained Earnings	1,084	900.27	551.4	674.32	611.4	479
Treasury Stock	-	-	-	-	-	-5.28
Comprehensive Income & Other	1.42	1.42	-	-	-	-
Total Common Equity	2,163	1,978	1,593	1,690	1,552	1,344
Shareholders' Equity	2,163	1,978	1,593	1,690	1,552	1,344
Total Liabilities & Equity	2,743	2,539	2,128	2,024	1,783	1,687

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	59.16	82.03	215.31	79.15	13.81	111.28
Net Cash (Debt)	407.09	311.69	154.81	401.27	501.64	575.08
Net Cash Growth	110.53%	101.33%	-61.42%	-20.01%	-12.77%	-
Net Cash Per Share	1.14	0.87	0.44	1.14	1.43	1.77
Filing Date Shares Outstanding	357.32	357.32	355.76	354.08	352.34	350.52
Total Common Shares Outstanding	357.32	357.32	355.76	354.08	352.34	350.52
Working Capital	495.17	429.9	368.44	645.07	712.72	717.59
Book Value Per Share	6.05	5.54	4.48	4.77	4.41	3.84
Tangible Book Value	1,950	1,755	1,459	1,612	1,525	1,322
Tangible Book Value Per Share	5.46	4.91	4.10	4.55	4.33	3.77
Buildings	532.52	528.48	517.5	476.93	470.69	350.19
Machinery	997.29	964.78	759.99	711.75	534.35	481.36
Construction In Progress	533.72	380.26	196.85	106.16	70.12	34.94

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error